Dr. Zhonglin Hao
Claim this profileUniversity of Kentucky/Markey Cancer Center
Studies Lung Cancer
Studies Small Cell Lung Cancer
10 reported clinical trials
25 drugs studied
Area of expertise
1Lung Cancer
Stage IV
EGFR positive
2Small Cell Lung Cancer
Affiliated Hospitals
Clinical Trials Zhonglin Hao is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
CAR T-Cell Therapy
for Small Cell Lung Cancer
This trial tests specially modified immune cells in patients with advanced lung cancers. These immune cells are designed to find and destroy cancer cells by targeting a specific protein on them.
Recruiting1 award Phase 112 criteria
More about Zhonglin Hao
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Zhonglin Hao has experience with
- Topotecan Hydrochloride
- Copanlisib
- Durvalumab
- Docetaxel
- ONC-392
- LB2102
Breakdown of trials Zhonglin Hao has run
Lung Cancer
Small Cell Lung Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Zhonglin Hao specialize in?
Zhonglin Hao focuses on Lung Cancer and Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are EGFR positive.
Is Zhonglin Hao currently recruiting for clinical trials?
Yes, Zhonglin Hao is currently recruiting for 4 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Zhonglin Hao has studied deeply?
Yes, Zhonglin Hao has studied treatments such as Topotecan Hydrochloride, Copanlisib, Durvalumab.
What is the best way to schedule an appointment with Zhonglin Hao?
Apply for one of the trials that Zhonglin Hao is conducting.
What is the office address of Zhonglin Hao?
The office of Zhonglin Hao is located at: University of Kentucky/Markey Cancer Center, Lexington, Kentucky 40536 United States. This is the address for their practice at the University of Kentucky/Markey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.